9
Views
1
CrossRef citations to date
0
Altmetric
Research Article

LITERATURE ALERTS

Pages 793-807 | Published online: 29 Sep 2008

References

  • A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses. CHILDERS, N. K, TCI\U G, MITCHELL S., KIRK, K, RIRSFJI, M W, and MICHALEK, S. M. Infection Immunology, 1999, 67 (2), 618–623.
  • A hydrazino nicotinamide derivative of cholesterol for radiolabelling liposom es with 99m Tc. J1]DIE1 L. M., OLEARY, D. J., FM, G, SKENES, C., PAQUETTE T., and PRQFHTT, R T. Journal of Labelled Compound Radiopharmacy, 1999, 42 (1), 23–28.
  • A liposomal model that mimics the cutaneous production of vitamin D3. Studies of the mechanism of the membrane-enhanced thermal isomerization of previtamin D3 to vitamin D3. TIAN X. Q, and HCUCK M. F. Journal of Biological Chemistry, 1999, 274 (7), 4174–4179.
  • A method for quantifying differential expansion within hydrating hydrophilic matrixes by tracking embedded fluorescent microspheres. ADLER, J., JAYAN A, and MELIA, C. D. Journal of Pharmaceutical Science, 1999, 88 (3), 371–377.
  • A novel approach to biotransformations in aqueous-organic two-phase systems: enzymatic synthesis of alkyl beta-(D)-glucosides using microencapsulated beta-glucosidase. YT, Q, SARNEY, D. B., KHAN J. A., and VULFSCN E. N. Biotechnology and Bioengineering, 1998, 60 (3), 385–390.
  • A novel fabrication of poly(epsilon-caprolactone) microspheres from blends of poly(epsilon-caprolactone) and poly(ethylene glycol)s. LIN W. J., DAMON D. R., and LINHARDT, R. J. Polymer, 1998, 40 (7), 1731–1735. 1999.
  • A novel strategy for the preparation of liposomes: rapid solvent exchange. BU1CLT4 J. T., and FEIGENSCIN G W. Biochimica et Biophysica Acta, 1999, 1417 (2), 232–245.
  • A phase II study of liposom al doxorubicin in the treatment of HIV-related Kaposi's sarcoma. NEWELL, M., M1LUKEN S., GCLESTEIN D., LEWIS, C., BO/1F M, DCLAN G, RYAN S., and CCCFER, D. A. Australian and New Zealand Journal of Medicine, 1998, 28 (6), 777–783.
  • A study on microencapsulation of textile finishing agent—Microencapsulation of water repellent agent. KIM J. H., YOEN J. Y., and LlT Y. H Han' guk Somyu Konghakhoechi, 1998, 35 (12), 803–808.
  • A trial of clodronate-liposom es as anti-macrophage treatment in a sheep model of arthritis. HIGHICIS J., GUEVRENENT, D., THaVECN J., CARLISLE B., and TUCKER, I. Clinical and Experi-mental Rheumatology, 1999, 17 (1), 43–48.
  • Absorption and biodistribution of 111indium -labelled desferrioxamine (111In-DFO) after subcutaneous injection of 111In-DFO liposom es. PCSTMA N. S., BCERMAN 0 C., OYB\I W. J., ZULDEMA, J., and STCRM G. Journal of Controlled Release, 1999, 58 (1), 51–60.
  • Acetazolamide-induced increase in blood flow to rabbit organs is confirmed using colored microspheres. TAM, K, HIRAHARA K., TOVITA S., and TOICKI T. Heart and Vessels, 1998, 13 (2), 63–67.
  • Adsorption of protein on polystyrene microspheres modified with phosphoric acid moiety. SUGYAMk, K., YCSHICKA, T., and SHIRAISHI K. Kinki Daigaku Kogakubu Kenkyu Hokolai, 1998, 32, 35–41.
  • Advances in researches on new therm osensitive liposomes. YUAN S., CHEN Y., and DIM; Y. Shenyang Yaoke Daxue Xuebao, 1998, 15 (4), 299–302.
  • Aerosol delivery of liposom al all-trans-retinoic acid to the lungs. PARTHASARATHY, R., GILBERT, B., and MEHTA K. Cancer Chemotherapy Pharmacology, 1999, 43 (4), 277–283.
  • Aggregation behavior of gel microspheres of it-poly(methyl methacrylate) from xylene solution. TAKAHASHI, T., KCNMA, K., and MAECAWA, T. Polymer, 1999, 40 (12), 3301–3307.
  • Aging of soya-PC liposom es containing vitamin E reverses the stimulating effects of freshly prepared liposomes on growth of fibroblasts in culture. BERRCCAL M C., BUEAN J., MRADQ F., and AM-FR, A. Drug Delivery, 1998, 5 (4), 243–250.
  • Altered metabolism of all-trans-retinoic acid in liposome- encapsulated form. PARTHASARATHY, R., and MEHTA, K. Cancer Letters (Shannon, Ireland), 1998, 134 (2), 121–128.
  • An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposom al amphotericin B for treatment of invasive aspergillosis. ELLIS, M., SFENCE, D., DEPAUW, B., MEUNIER, F., MARINE, A, CCLLETTE, L., SYLVESTER, R, MEIS, J., BCCCAERTS, M., SELLESLAQ D., KRCIVERY, V., VCNSINNIER, W., MACDCNALD P, DOJEIS C., and VANDERCAM B. Clinical Infectious Diseaes 1998, 27 (6), 1406–1412.
  • Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes. PETRIKCMCS, I., HCINQ K, ()MIRO G., HU Q Z, PH, L., MOGLINNI W. D., SYLVESTER, D., TAMJLINAS, C., PAPAHADICPOULGS, D., JASZBERENYI, J. C., and WAY, J. L. Toxicology and Applied Pharmacology, 1999, 156 (1), 56–63.
  • Antimicrobial properties of liposomal polymyxin B. MCALLISTER, S. M, ALPAR, H 0, and BROAN M. R. W. Journal of Antimicrobial Chemotherapy, 1999, 43 (2), 203–210.
  • Antioxidant activity of quercetin and myricetin in liposomes. GCRECN M H., and ROHM P A. Chemical Physical Lipids, 1998, 97 (1), 79–85.
  • Antitumor effect of cisplatin incorporated into polylactic acid microcapsules. ARAM, H., TAN, T., and KCHAMA, M. Artificial Organs, 1999, 23 (2), 161–168.
  • Apolipoprotein B stimulates formation of monocyte-macrophage surface-connected com-partments and mediates uptake of low density lipoprotein-derived liposomes into these compartments. KRUM H. S., ZHANO W. Y., SKARLATCS, S. I., and CH AO F. F. Journal of Biological Chemistry, 1999, 274 (11), 7495–7500.
  • Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. IWANACA K, ONO S., NARICKA K, KAKEM, M., MCRIVDIO K, YAMASHITA S., NAM1A Y., and 014 N. Journal of Pharmaceutical Science, 1999, 88 (2), 2/18 252.
  • Bilayer permeability-based substrate selectivity of an enzyme in liposomes. WALDE, P, and MARZETTA B. Biotechnology and Bioengineering, 1998, 57 (2), 216–219.
  • Binding of adriamycin to liposomes as a probe for membrane lateral organization. SODERLUND, T., JUITLA A, and KININUINEN P. K. J. Biophysics Journal, 1999, 76 (2), 896–907. Biodegradable microspheres having reactive groups prepared from L-lactic acid-depsipep- tide copolymers. Mal, T., HAMADA, A., and OHYA Y. Macromolecular Chemical Physics, 1999, 200 (2), 436dill.
  • Biodegradable poly(DL-lactic-co-glycolic acid) microspheres containing tetracaine hydro-chloride. In-vitro release profile. RAMREZ L., PASTCRIZA P, and HERRERO V. R. Journal of Microencapsulation, 1999, 16 (1), 105–115.
  • Biologically active polymeric microspheres. YAN C., XIJ Z, CHENO S., and FEN.? L. Gaofenzi Cailiao Kexue Yu Gongcheng, 1999, 15 (1), 1–4.
  • Biosensors based on thin lipid films and liposomes. NIKCLIIIS, D. P., HIAINIK T., and KRITI, U. J. Electroanalysis, 1999, 11 (1), 7–15.
  • Cadmium removal from human plasma by Cibacron Blue F3GA and thionein incorporated into polymeric microspheres. IBRAHIM E. H., DENIM, A, BEICTACS, S., GENCQ O., and PICSKIN E Journal of Chromatography. B, Biomedical Sciences and Applications, 1998, 720(1-2), 217–224.
  • Calpain inhibitor entrapped in liposome rescues ischemic neuronal damage. YCKOTA M., TAN, E, TSUBLICI, S., YAMAURA, I., NAKAGAKI, I., HCRI, S., and SAIDC) T. C. Brain Research, 1999, 819 (1-2), 8–14.
  • Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon. MURRAY, K D., MOQUILLIN A., STEWART, L., ETHERIDCF; C. J., CCCFER, R G, MILLER, A D., and GURLINO H. M. D. Gene Therapy, 1999, 6 (2), 190–197.
  • Cationic liposome mediated transgene expression in the guinea pig cochlea. WAREINQ M., MHATRg A N., PETTIS, R., HAN J. J., HAUT, T., PFISTER, M H., HCNO K, ZHENQ W. W, and LALWAN, A. K Hearing Research, 1999, 128 (1-2), 61–69.
  • Characteristics of microencapsulated PCM slurry as a heat-transfer fluid. YAMAGISHI, Y., TAKIEUal, H., PYATENKC) A. T., and KAYUKAWA N. AIChE Journal, 1999, 45 (4), 696–707.
  • Characterization of drug release from liposomal formulations in ocular fluid. JAFARI, M. R., JCNES, A. B., HIKAL, A H., WILITAIVBC/S J. S., and WYAINDT, C. M Drug Delivery, 1998, 5 (4), 227–238.
  • Chem o-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy. BASTIAN P, BARTICOASKI, R., KCHLER, H., and KISSEL, T. European Journal of Pharmaceutics and Biopharmaceutics, 1998, 46 (3), 243–254.
  • Chromatographic approaches to liposomes, proteoliposomes and biomembrane vesicles. LUNDAHL, P, ZENQ C. M., LAGERCILIST, H. C., GOTTSCHALK I., and GREUER, E Journal of Chromatography, B: Biomedical Science Applications, 1999, 722 (1+ 2), 103–119.
  • Colonic wall thickening is related to age and not dose of high strength pancreatin micro-spheres in children with cystic fibrosis. CONINETT, G. J., LUCAS, J. S., ATCHLEY, J. T., FAIRHURST, J. J., and RCLLES, C. J. European Journal of Gastroenterology and Hepatology, 1999, 11 (2), 181–183.
  • Comparative degradation study of biodegradable microspheres of poly (DL-lactide-co-glyco-lide) with poly(ethylene glycol) derivatives. GARCIA, J. T., FARINA, J. B., MUNUIA O., and LIARS, M. Journal of Microencapsulation, 1999, 16 (1), 83–94.
  • Comparative efficacy of liposom al FK506 with FK506. MCFFATT, S. D., MCALISTER, V., CALNE R. Y., and METCALFE S. Transplant Proceedings, 1998, 30 (8), 4066–4067.
  • Comparative intravenous toxicity of cisplatin solution and cisplatin encapsulated in long-circulating, pegylated liposomes in cynomolgus monkeys. WCRICEN, P. K, NEWMAN M. S., SI IIIVAN T., BRUNNER, M., PODELL M., SAHENIc Z, and TURNER, N. Toxicological Sciences, 1998, 46 (1), 155–165.
  • Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. NEWMAN M. S., CCLBERN G T., waucmq P. K, ENGBERS, C, and AMANI'EA, M. A. Cancer Chemotherapy Pharmacology, 1999, 43 (1), 1–7.
  • Conjugation of drug to poly(D, L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.J. E., NAM Y. S., LIT K H., and PARK, T. G. Journal ofControlled Release, 1999, 57 (3), 269–280.
  • Contact hypersensitivity: a simple model for the characterization of disease-site targeting by liposomes. KUMUK S. K, SEM=Lg S. C., SCHERREK P, and HCM M J. Biochimica et Biophysica Acta, 1999, 1417 (2), 191–201.
  • Covalent immobilization of unilamellar liposomes in gel beads for chromatography. YANC 0, LILI X. Y., YC8HIMDTC) M., KUBCI, R., and MIYAKE J. Analytical Biochemistry, 1999, 268 (2), 354–362.
  • Current status of cationic liposome-mediated gene therapy in cystic fibrosis. CCLCEIMi) A., SANCIUCLQ F., DI SARIQ S., AMCIM, P., SERAFINO A L., NOVELL', A, SAM', M., CASTRO M., LUCID, V., MCSSA, G., DALLNFUMA B., and NO/ELU, G Acta Pharmaceutica (Zagreb), 1998, 48 (4), 221–227.
  • Cyclic voltammetric studies of pasted nickel hydroxide electrode microencapsulated by cobalt. WAN U X. Y., YAN J., ZHANO Y. S., YUAN H T., and SCNO D. Y. Journal of Applied Electrochemistry, 1998, 28 (12), 1377–1382.
  • Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. CAQ X., and SCILICHET, M S. Biomaterials, 1999, 20 (4), 329–339.
  • Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules. RCS, C. J. D., RALFEI M., and CHAIN. P. L. Human Gene Therapy, 1999, 10 (1), 49–59.
  • Derivative assay of cisplatin bletilla striata microspheres for hepatic targeting. LI, W, CHEN H., and CHEN J. Guangpu Shiyanshi, 1998, 15 (6), 62–65.
  • Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. SLIECREGT, L. A J. M, RENSEN P C. N., RUVP, E T., VANSANTIIIINK P. J., BLISTERBESCII M K, VALENMN A R P M., VAN DER MAREL, G A, VAN BCCM J. H., VAN BERKE, T. J. C., and BIESSEN E A L. Journal of Medical Chemistry, 1999,42 (4), 609–618.
  • Destabilase complexes—natural liposome produced by medicinal leeches Hirudo medici-nalis. NIKCNIT, G. I., and TITCYA E. A. Fundamentals of Clinical Pharmacology, 1999, 13 (1), 102–106.
  • Determination of the internal morphology of poly (D, L-lactide) microspheres using stereo-logical methods. EHIEZAZI, T., WASEINGIEN C., and MELIA C. D. Journal of Controlled Release, 1999, 57 (3), 301–314.
  • Differential transmembrane diffusion of triiodothyronine and thyroxine in liposomes: regu-lation by lipid composition. CHEEIN R. N., ISSF, B. G., RINPOUL, M. R, and FARIAS, R. N. Journal of Membrane Biology, 1999, 167 (3), 251–256.
  • Differential uptake of conventional and polyethylene glycol m odified-alkylphosphocholine-liposom es by J774A.1 murine macrophages. EUg I. Drug Delivery, 1998, 5 (4), 265–273.
  • Diode laser-induced thermal damage evaluation on the retina with a liposome dye system. DESIVETTRg T. J., SCULIE, B. S., DEVCISSELLE J. M., and MCRECN S. R Lasers in Surgery and Medicine, 1999, 24 (1), 61–68.
  • Direct in vivo gene transfer to healing rat patellar ligament by intra-arterial delivery of haemagglutinating virus of Japan liposomes. OZKAN I., SEM) K, NAKAMURA, N., NATSUUVE, T., MATSUIVDTQ N., HCRIPE, S., TC/vITA T., KANEDA Y., and CCH, T. European Journal of Clinical Investigations, 1999, 29 (1), 63–67.
  • Direct qualitative and quantitative characterization of a radiosensitizer, 5-iodo-2'-deoxyur-idine within biodegradable polymeric microspheres by FT-Raman spectroscopy. GF/F, A, BOURY, F., BENCIT, J. P., CE12URPA I., and DUBCIS, P. Analyst (Cambridge, UK), 1999, 124 (1), 37–42.
  • Disposable liposome immunosensor for theophylline combining an immunochrom ato-graphic membrane and a thick-film electrode. LEE K. S., KIM T. H., SHIN M. C., LEE W. Y., and PARK, J. K. Analytical Chimica Acta, 1999, 380 (1), 17–26.
  • Distinctive features of the formation of microspheres by spraying molten metal. TERNCIvII, Y. F., KIIINWHINKO A. B., and PARAIINA, G I. Powder Metallurgy, Metals and Ceramics, 1998, 37 (3-4), 132–136.
  • Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog. KIYCKAWA H, IGAWA Y., MURAISH, O., KATSUYAMA, Y., HMO, K., and NISHZAWA O. Journal of Urology (Baltimore), 1999, 161 (2), 665–667.
  • DSC and NMR spectroscopic studies of the interaction between camphorated phenol and phospholipid liposomes. FUISAWA S., KADCMA, Y., and ITO S. Dental Materials Journal, 1998, 17 (4), 314–320.
  • Effect of adrenalectomy on the slimming activity of liposome-carried oleoyl-estrone in the rat. GRAS A M. M., CABCF, C., AD AN C., VILA, R., ESTEVE M., ESTRUM J., FERNAINEEZLCFEZ J. A., REMESAR, X., and ALEMANY, M. International Journal of Obesity, 1998, 22 (12), 1225–1230.
  • Effect of antioxidants on the kinetics of chain lipid peroxidation in liposomes. VASILJEVA 0 V., LYUITSKY, 0 B., KLEPANN, G. I., and VLAEIMRCV, Y. A Membrane and Cell Biology, 1998, 12 (2), 223–231.
  • Effect of brain sodium channel I54 segment on liposome structure. LUC) X., ZHANG R., ZHAO N., YANG L., and NI E S. Qinghua Daxue Xuebao, Ziran Kexueban, 1998, 38 (10), 113–115.
  • Effect of drug properties on the release from CAP microspheres prepared by a solvent evaporation method. SILVA J. P. S., and FERREIRA J. P. M. Journal of Microencapsulation, 1999, 16 (1), 95–103.
  • Effect of lipid with covalently attached poly(ethylene glycol) on the surface properties of liposomal bilayer membranes. YCSHILA, A., HASHIZAKI, K., YAMAUCH, H., SAKAI, H., YCKCIAMA, S., and AW M. Langmuir, 1999, 15 (7), 2333–2337.
  • Effect of polyethyleneglycol modification on tumor cell uptake of antitumor agent encapsu-lated liposomes. HIROTA S., KANACAWA A., and MCRITA T. Drug Delivery Systems, 1998, 13 (6), 415–421.
  • Effect of polymer architecture on the interactions of hydrophobically-modified poly(N-isopropylam ides) and liposomes. PanzarA, A, YAmAzAK, A, BRASI-i J. L., and WINNK F. M. Colloids Surfactant, A, 1999, 147 (1-2), 17–25.
  • Effective irinotecan (CFT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38. SABZUKA, Y., HIROISIJ S., and HIROTA S. Japanese Journal of Cancer Research, 1999, 90 (2), 226–232.
  • Effectiveness of ciprofloxacin microspheres in eradicating bacterial biofilm. OWUSU, A. G., RCGERS, J., and ANWAR, H. Journal of Controlled Release, 1999, 57 (2), 151–159.
  • Effects of inhaled gases on the ultrasound contrast produced by microspheres containing air or perfluoropropane in anesthetized dogs. WIRIF, J. JR, WODYLA, J., BLEK J., and BRANCENIRGER, G. Investigating Radiology, 1998, 33 (12), 871–879.
  • Effects of liposome-encapsulated hemoglobin on phorbol ester-induced superoxide produc-tion and expression of costimulatory molecules by monocytes in vitro. FUIHARA, M., IKEBUCH, K, YAMAGUCHI, M., AW H., NIWA K, and SEKIGUCH, S. Artificial Cells, Blood Substitutes, Immobilization Biotechnology, 1998, 26 (5 & 6), 487–495.
  • Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum. SILVANDER, M., JCHN3SC1 M., and EDWARES, K Chemical and Physical Lipids, 1998, 97 (1), 15–26.
  • Effects of urea and trim ethylamine N-oxide on fluidity of liposomes and membranes of an elasmobranch. BARTOS K. N., BUHR, M. M., and BALLANTYNE J. S. American Journal of Physiology, 1999, 276 (2, Pt. 2), R397—R406.
  • Efficient encapsulation of plasmid DNA in anionic liposomes by a freeze/thaw-extrusion procedure. SCI-EEN P., BM, L., and WILSCHUT, J. Journal of Liposome Research, 1998, 8 (4), 485–497.
  • Electrokinetic study of the sublytic interaction of alkyl sulfates with phosphatidylcholine liposomes. CCCERA M., LCFEz 0, DE LA MAZA, A., PARRA, J. L., and ESTELRICH J. Langmuir, 1999, 15 (6), 2230–2233.
  • Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) micro-spheres as a novel approach for immunogene delivery. WANG D., RCBINKIN D. R., KACIS G S., and SAMJEL J. Journal of Controlled Release, 1999, 57(1), 9–18.
  • Encapsulation of the topoisom erase I inhibitor GL147211C in pegylated (Stealth) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts. CCLBERN G T., DYKES, D. J., ENUBERS, C., MLSTERER, R., Hill FR, A, PEGG E, SAVIJIF, R, WEN S., LI WIQ M., USTER, P., AMANI'EA, M., and WCRKING P. K. Clinical Cancer Research, 1998, 4(12), 3077–3082.
  • Engineering stealth liposome surfaces: exercises in. KCSTARELC8, K. NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 139–145.
  • Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. PULFER, S. K, and GALLQ J. M. Journal of Drug Targeting, 1998, 6 (3), 215–227.
  • Enhancement of gentamicin and nystatin microbial activity using liposomes as drug carrier. ABUZAID S. S., and AEnaRAHmAN A. A. Al-Azhar Journal of Pharmaceutical Science, 1997, 20, 12–25.
  • Enhancement of radiomodulatory effect through liposome encapsulated radio-modifier on cancer bearing mice. ALAM A., CHARRABCRTY, S., RAPTHAF, C., SRIVASTAVA P. N., and SHARAN R. N. Schr Forschungszent Juelich, Bilateral Semin Int Bur, 1999, 30 (Recent Aspects of Cellular and Applied Radiobiology), 83–88.
  • Environmental estrogen-mimics display liposomal membrane-antioxidant ability: import-ance of molecular modeling predictions. LEADLEY, J., LEVMS, D. F. V., WISIIVIAN H., GCLEFARR P. S., and WISEMAN A. Journal of Chemical Technology and Biotechnology, 1998, 73 (2), 131–136.
  • Enzymic reactions in liposomes using the detergent-induced liposome loading method. OEERWL,ZER, T., MEYER, E., AMATO I., LLSTIQ A., and MCNNAM, P. A Biochimica et Biophysica Acta, 1999, 1416 (1-2), 57–68.
  • Enzymological and medical applications of hybrid liposomes. UBOKA, R., and MATSLIVDPQ Y. Recent Research and Developments in Organic Chemistry, 1997, 1, 347–363.
  • Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatographic assay. BAIN D. F., MUNDAY, D. L., and CCPC, P. J. European Journal of Pharmaceutical Science, 1998, 7 (1), 57–65.
  • Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal admin-istration to rats. LUFTENSTEINER, C. P., SCHWENDENWFIN I., PAUL, B., EICHLER, H. G, and VIERNSTEIN H. Journal of Controlled Release, 1999, 57 (1), 35dd.
  • Evaluation of toxicosis of liposome-encapsulated cis-bis- neodecanoato-trans-R, R-1,2-di-aminocyclohexane platinum (II) in clinically normal cats. FCK L. E, TCSHACH K, CALEERWID, M. M., KFIKHAR, A R., KUBILIS, P., PERE4 S. R, and MACEWEN E G American Journal of Veterinary Research, 1999, 60 (2), 257–263.
  • Evidence for phosphoprotein microspheres in bone. CARIIR, D. H., SCULLY, A J., DAVIES, R. M., and AARON J. E. Histochemistry Journal, 1998, 30 (9), 677–686.
  • Experimental studies on galactolipid modified liposome targeting to liver. CI-IAN G., DUAN F., SHEN J., and YAIN. S. Zhonghua Heyixue Zazhi, 1998, 18 (4), 206–208.
  • Experimental study of the effects of cholesterol liposome on rabbit sphincter of Oddi cell proliferation in culture. ZHAIN J., WEL J., WI J., ZHAIN Y., and WAN H Disi Junyi Daxue Xuebao, 1998, 19 (5), 494–497.
  • Fabrication of new porcelain bodies in the system of glass microspheres-quartz-aluminous cement. TAI, W. P., KIMURA, K, TATEYAMA, H., YAMADA, N., and JINN AI, K Journal of the Ceramic Society of Japan, 1999, 107 (Jan), 8–14.
  • Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. LEVI, M., FRIEDERICH P. W., MBDDLETCN S., DEGRCOT, P. G, Wt Y. P, HARIUS, R., BlEvIiNE1 B. J., HELENE'S H. F. G., LEVIN J., and WOUTER TENCATE J. National Medicine (NY), 1999, 5 (1), 107–111.
  • Fluorometric phospholipase assays based on polymerized liposome substrates. CI-I) W, WLI S. K, YCCIN E, and LICHTENBERGCWA L. Methods in Molecular Biology (Totowa, NJ), 1999, 109 (Lipase and Phospholipase Protocols), 7–17.
  • Formulation design and optimization of modified-release microspheres of diclofenac sodium. GCHEL, M. C., and AMN A. F. Drug Development and Industrial Pharmacy, 1999, 25 (2), 247–251.
  • Formulation factors affecting drug release from poly(lactic acid) (PLA) microcapsule tablets. KACER, A., and JALIL, R. Drug Development and Industrial Pharmacy, 1999, 25 (2), 141–151. Formulations and pharmacokinetics of sterically stabilized liposomes. GRCHMANN F. L. Gyogyszereszet, 1998, 42 (11), 587–591.
  • Fructose protects rat hepatocytes against hypoxic injury during the process of isolation and microencapsulation. YLI C. H., LEN X. S., PEN U J. R, WH, Y. H, LILI J. C, and DLI R. Y. Transplantation Proceedings, 1999, 31 (1-2), 1080–1083.
  • Fungal infection and liposom al am photericin B (Am I3isom e) therapy in liver transplantation: a 2 year review. FISHER, N. C., SINUFIAL S., MIIIFR, S. J., HASTIN5S, J. G. M, and MUTilviR, D. J. Journal of Antimicrobial Chemotherapy, 1999, 43 (4), 597–600.
  • Fusion of sendai virus with liposome depends on only F protein, but not HN protein. MIZUGUCH, H, NAKANSH, T KCNXII M., NAKACAWA, T., NAKANSH, M, MATSUYAMA, T., TSUTSUM, Y., NAKACAWA S., and MAYUM, T. Virus Research, 1999, 59 (2), 191-201. GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide. PAGNAN G, MCNTALDC) P. G, PASTCRIND F., RAFFACIHELLQ L., KIRCHMHEK M., ALLEN T. M., and PCNZCNI, M. International Journal of Cancer, 1999, 81 (2), 268–274.
  • Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint. BRCMN K E., LECNG K, HUANG C. H., DALAI., R, GREEN G D., HAINES, H B., JIIvENE4 P A., and BATFCN J. Arthritis and Rheumatism, 1998, 41 (12), 2185–2195.
  • Gene expression and antitumor effects following direct interferon (IFN)-7 gene transfer with naked plasm id DNA and DC-chol liposome complexes in mice. NCIVLIRA, T., YASLEA, K, YAMADA, T., OKAMDTQ S., MAHATC) R. I., WATANBF Y., TAKAKLRA, Y., and HASHIDA, M. Gene Therapy, 1999, 6 (1), 121–129.
  • Graft copolymers having hydrophobic backbone and hydrophilic branches. XVI. Polystyrene microspheres with poly(N-isopropylacrylamide) branches on their surfaces: size con-trol factors and thermosensitive behavior. CHEN M 0, SERIZAWA, T., and AKASFIL M. Polymer Advances in Technology, 1999, 10 (1-2), 120–126.
  • Granulocyte-macrophage colony-stimulating factor protects dendritic cells from liposome-encapsulated dichlorom ethylene diphosphonate-induced apoptosis through a Bc1-2-mediated pathway. RABINGVICII G. A., RIERA, C. M., and IRIBARREN P European Journal of Immunology, 1999, 29 (2), 563–570.
  • Growth of human fetal retinal pigment epithelium as microspheres. GABRIELIAN K, CGAI\ESIAN A., FARRCKH S. L., REZAI, K A., VERE M. S., PATEL, S. C., and EMNEST, J. T. Graefes Archive for Clinical and Experimental Ophthalmology, 1999, 237 (3), 241–248.
  • Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-05a antibody. SZEBEINI, J., FCNTANA, J. L., WASSEF, N. M., MC:WAN P. D., MCRSE D. S., DCBRINS, D. E, STAHL, G L., BUNGER, R., and ALVIMI C. R. Circulation, 1999, 99 (17), 2302–2309.
  • Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres. HAFFEU, U. O., CASILLAS, S., DILL D. W, PALER, G J., RYBICKI L. A., CCINZI2M S. D., and DAY, D. E International Journal of Radiation Oncology, Biology, Physics, 1999, 44 (1), 189–199.
  • Histological methods to determine blood flow distribution with fluorescent microspheres. LUCHTEL, D. L., BO/KEN J. C., BERNARLI S. L., and GUNNY, R W. Biotechnic and Histochem-istry, 1998, 73 (6), 291–309. 26 Refs.
  • Hollow alumina microspheres from boehmite sols. CHATTERIEE M., ENKHTUVSHIN D., SMACITYA, B., and GAN3ULI, D. Journal of Materials Science, 1998, 33 (20), 4937–4942.
  • HPLC determination of clofazimine in tissues and serum of mice after intravenous admin-istration of nanocrystalline or liposom al formulations. MINER, K, HARTVMQ H., LEITZKE S., HAHN H., MI Jr I FR, R. H., and EFLERS, S. International Journal of Antimicrobial Agents, 1999, 11 (1), 75–79.
  • HVJ-liposome mediated gene transfer into hepatocytes in vivo. HIRAM) T., FUJIMTC) J., Ulla, T., YAMANDPQ H., TAKEUCHI, M., MAWR) E, TAKAHASHI, H, MCRISITA R, SAWA, Y., and KANEDA, Y. Journal of Hepatology, 1998, 29 (6), 910–914.
  • Hydrazide-functionalized poly(2-hydroxyethyl methacrylate) microspheres for immobiliza-tion of horseradish peroxidase. HCRAK D., KARFISEK M, TURKG,TA, J., and BENES, M. Biotechnology Progress, 1999, 15 (2), 208–215.
  • Hydrogel microspheres for flutamide obtained by multiple emulsions. LAMAS, M C., BRB3NI, C, FRIAS, M., and VELAZQUEZ R. ST P Pharma Science, 1998, 8 (6), 375–378.
  • Hyperthermia enhancement by thermosensitive liposomes as a drug delivery system for malignant gliom a chemotherapy. KAKINUMA K, TANAKA, R., and KATO M Drug Delivery Systems, 1998, 13 (6), 389–399.
  • Identification of the in vivo topically applied 'human-identical' ceramides included in negatively charged liposomes. RCCRIGUES, L., DA SILVA P A., PINTO P., GALBCCI N., SILVA N., and PEREIRA, L. M. Boll Chim Farm, 1998, 137 (10), 395–402.
  • Imaging experimental intraabdominal abscesses with 99m Tc-PEG liposomes and 99m Tc-HYNIC IgG. DAIVE, E. T., RHINEN M. M., OYEN W. J., BCERMAN 0 C., LAVERMAN P, STCRM G, VANDER MEER, J. W., CCRSTEINE, F. H., and VANGCCR, H. Annals of Surgery, 1999, 229 (4), 551–557.
  • Immunization with recombinant class 1 outer-membrane protein from Neisseria meningi-tidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response. CHRISTCEOULMES, M., BRCCKS, J. L., RATTUE, E., and HKKELS, J. E. Microbiology, 1998, 144 ( Pt 11), 3027–3037.
  • Improved function of microencapsulated hepatocytes in a hybrid bioartificial liver support system. DIXIT, V., ARTHLR, M., RIIINHAIIDI', R., and GITINICK G Artificial Organs, 1992, 16(4), 336–341.
  • In vitro binding of HSA, IgG,, and HDL on liposomes of different composition and its correlation with the BLOOD/RES ratio of liposomes. PANG, Z, AVGCLSTAKIS, K, EVANCHARD, G., and ITHAKISSICS, D. S. International Journal of Pharmacy, 1999, 176 (2), 203–207.
  • In vitro investigation of ionic polysaccharide microspheres for simultaneous delivery of chemosensitizer and antineoplastic agent to multidrug-resistant cells. LIU, Z, X. Y., and BENEAYAN R Journal of Pharmaceutical Sciences, 1999, 88 (4), 412–418.
  • In vitro study of multicellular hepatocyte spheroids formed in microcapsules. ITQ Y., and CHANQ T. M. Artificial Organs, 1992, 16 (4), 422–427.
  • In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. DE1VES, S. M., ALKAN 0 H., KANE R J., RAMAN, K, MURAT, A., GREENE, R., KLBGERMAN M., and MCPHERSCNI D. D. Journal of The American College of Cardiology, 1999, 33 (3), 867–875.
  • Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum. SANGAI1E, L., MCRISSET, R, OPvRI, A., and RAVACARINCRQ M. Journal of Antimicrobial Chemotherapy, 1998, 42 (6), 831–834.
  • Induction of interferon synthesis and activation of interferon-stimulated genes by liposom al transfection reagents. LI, X. L., BCYANAPALu, M., WIIHUA, X, KALVAKCLANU D. V., and HASSEL, B. A. Journal of Interferon Cytokine Research, 1998, 18 (11), 947–952.
  • Induction of protective T cells against Listeria monocytogenes in mice by immunization with a listeriolysin 0-negative avirulent strain of bacteria and liposome-encapsulated listeriolysin 0. TANABE Y., XIC7\ H., NOVIURA, T., ARAKAWA M., and MITSUYAIVIA M. Infection and Immunology, 1999, 67 (2), 568–575.
  • Inflammatory cytokine production in whole blood modified by liposome-encapsulated hemoglobin. NIWA K, IKEBUCH, K, FUIHARA, M, ABE H., WAKAMIFQ S., ITQ T., YAMAGUal, M., and SEKIGUCHL S. Artificial Cells, Blood Substitutes, Immobilization Biotechnol-ogy, 1998, 26 (5 & 6), 559–570.
  • Influence of cholesterol liposome immunization and immunostimulation on rabbit athero-sclerosis induced by a high cholesterol diet. ISTVAN H, SZEIIE, B., ANNA H., IBCLYA K, and ATTILA, H Medical Science Monitoring, 1998, 4(3), 403–407.
  • Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa. BCCATAI, M, MRHAP., A., and KCRC8EC L. International Journal of Pharmacy, 1999, 177 (2), 211–220.
  • Inhibitory effects of EGFR antisense oligodeoxynucleotide with liposome in human colo-rectal cancer cell line. WI J. S., Fig Y., and WANC S. M. Huaren Xiaohua Zazhi, 1998, 6 (9), 762–764.
  • Interaction between a novel amphiphilic polymer and liposomes. HARA, M, MIYAKE, M., BA" S., YANQ Q., ARAI, T., YUAN H., and MIYAKE J. Suprconolecular Science, 1998, 5 (5-6), 777–781.
  • Interactions between vitamin A and vitamin E in liposomes and in biological contexts. LIVREA, M. A., and TESCRIERE L. Methods in Enzymology, 1999, 299 (Oxidants and Antioxidants, Part A), 421–430.
  • Interactions of oxyethylenated nonylphenols with liposomes mimicking the stratum cor-neum lipid composition. DE LAMAZA, A, LCIE4 0, CCIDERCH L., and PARRA, J. L. Colloids Surfactant, A, 1998, 145 (1–3), 83–91.
  • Interactions of polymeric and liposom al gene delivery systems with extracellular glycosa-minoglycans: physicochemical and transfection studies. RUIONEN M., YLA H. S., and URTTI, A. Biochimica et Biophysica Acta, 1999, 1415 (2), 331–341.
  • Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms. RAINCY, N. G., IKEDA, K, QURESH, N H., GRCAER, S., HERRLINSER, U., PBalAN P, CHOTA E A., BREAKEHELT1 X. O., and BARNETT, F. H Human Gene Therapy, 1999, 10 (2), 311–318.
  • Intracellular responses of hybrid liposomes against leukemia cells related to apoptosis with antitumor activity. MATSUNDTQ Y., KATQ T., KEMURA, Y., TSUCHIYA M., YAMAMDPQ M., and UECKA, R. Chemistry Letters,1999, (1), 53–54.
  • Intravenous pretreatment with empty pH gradient liposomes alters the pharmacokinetics and toxicity of doxorubicin through in vivo active drug encapsulation. MAYER, L. D., REA1VER, J., and BALLY, M. B. Journal of Pharmaceutical Sciences, 1999, 88 (1), 96–102.
  • Investigation of progesterone loaded poly(DL-lactide) microspheres using TMDSC, SEM and PXRD. HIU V. L., PASSEIUN, N., CRAIQ D. Q. M., VICKERS, M, ANWA, J., and FEELY, L. C. Journal of Thermal Analytical Calorimetry, 1998, 54 (2), 673–685.
  • Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens. LI, X., DFNI X., YUAN M., XIO\Q C., HUANQ Z, ZHANQ Y., and JIA, W. International Journal of Pharmacy, 1999, 178 (2), 245–255.
  • Ketoprofen-poly(0,L-lactic-co-glycolic acid) microspheres: Influence of manufacturing par-ameters and type of polymer on the release characteristics. GABCR, F., ERTL, B., WIRTH M., and MALLINUER, R. Journal of Microencapsulation, 1999, 16 (1), 1–12.
  • Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-resistant tuberculosis. WHITEHEAD T. C., LOVERING A M, CRCH_EY, I. M, WADE, P, and DAVILECN R. N. European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17(11), 794–797.
  • Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. WALSH T. J., FINPERQ R. W., ARNDT, C., HIENENZ J., SCHWARTZ C., BCCENSTETNER, D., PAFPAS, P., SHBEL N., GREENPERQ R N., DUMVER, S., SCI-1STER, M., and HaCENBERG J. S. New England Journal of Medicine, 1999, 340 (10), 764–771.
  • Liposom al amphotericin Bin neonates with invasive candidiasis. AL ARISH, H., FRAYHA, H. H., KALLOGHLIAN A, and AL ALAIYAN S. American Journal of Perinatology, 1998, 15 (11), 643-648. Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors. LIFF1ENS, R. J. J. Pediatric Hematology and Oncology, 1999, 16 (2), 131–139.
  • Liposom al daunorubicin: in vitro and in vivo efficacy in multiple myelom a. PRATT, G., WILES, M. E, RAV6TRON A. C., DAVIES, F. E, FENTCN J. A, PRCFHTT, J. A, CHILD J. A., SIVITH G M., and MCRGAN G. J. Hematological Oncology, 1998, 16 (2), 47–55.
  • Liposom al delivery of purified inhibitory-kappal3alpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. SELZMAN C H, SHAMES, B. D., REZNIKOW, L. L., MIIIFR, S. A., MENG X., BARTON1 H A, WERMAN A, HARKEN A H., DINARHICI C. A, and BAINERIEE A. Circulation Research, 1999, 84 (8), 867–875.
  • Liposom al DNA transfection of human sarcoma cells with p53 alterations. MEYE, A, WLRL, P, LCHN M., LASCI-t J., BACHE M., HINZE R., HCLZHAUSEN H J., SCHMIDT, H., RATE F. W., and TAUBERT, H. V erhandlungen Der Deutschen Gesellschaft Fur Pathologie, 1998, 82, 220–225.
  • Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal admin-istration of cationic liposome DNA aggregates. RHIVER, D. L., KONG S., MCNCK, M., WYLES, J., TAM P., WASAN E K, and BALLY, M. B. Journal of Pharmacology and Experimental Therapeutics, 1999, 289 (2), 807–815.
  • Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma in patients who were at high risk for relapse: An update. GIANAN M A V., and KLEINERMAN E. S. Cancer Biotherapy and Radiopharmacy, 1998, 13 (5), 363–368.
  • Liposom al nystatin against experim ental pulmonary aspergillosis in persistently n eu trope nic rabbits: efficacy, safety and non-compartmental pharmacokinetics. GRCLL, A. H., GaNzATEZ C. E., GIRT, N., KIIGYS, K, Lag W., PETER, J., FEGERSTHN E, BActiER, J., PISCITELLI, S. C., and WALSH T. J. Journal of Antimicrobial Chemotherapy, 1999, 43(1), 95–103.
  • Liposomal plant actives for skin lightening. BLUIT G., THCI-IMJELUER, E E, and ORNDCRFF, S. SOFW Journal, 1999, 125 (2/3), 20–24.
  • Liposome adhesion on mica surface studied by atomic force microscopy. ECAWA, H., and FIRLSAWA, K. Langmuir, 1999, 15 (5), 1660–1666.
  • Liposome as a drug carrier system: prospects for safer prescribing during pregnancy: A review. BAICRIA, R., and SCCRAININIA, S. R. Trophoblast Research, 1998, 12 (Maternal Fetal Interface), 265–287.
  • Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes. FUKASAWA M, SHMZU Y., SHKATA K, NAKATA M., SAKAMBARA R., YAMAMITTC) N., HATANAKA M, and MIZUCCI-11, T. FEBS Letters, 1998, 441 (3), 353–356.
  • Liposome-bound Zn(II)-phthalocyanine. Mechanisms for cellular uptake and photosensitiza-tion. RCEAL, G H., RCDAL S. K, MOAN J., and BERQ K Journal of Photochemical Photobiology, B, 1998, 45 (2-3), 150–159.
  • Liposome-skin interactions and their effects on the skin permeation of drugs. KIRIAVAINEN M., URTTI, A, VALJAKKA K. R., KIESVAARA, J., and MCNKKONEN J. European Journal of Pharma-ceutical Sciences; 1999, 7 (4), 279–286.
  • Liposomes as model membrane systems. BOTA, A., DRUCKER, T., and WINFRED K Olaf, Szappan, Kozmet, 1998, 47 (5), 244–250.
  • Liposomes fuse with sperm cells and induce activation by delivery of impermeant agents. GARRETT, F. E, GCEL S., YASUL, J., and KCCFt R. A. Biochimica et Biophysica Acta, 1999, 1417 (1), 77–88.
  • Liposomes promote pulmonary glucocorticoid delivery. SUNTRES, Z E, and SHEIc P. N. Journal of Drug Targeting, 1998, 6 (3), 175–182.
  • Liposomes with anti-oxidants and their protective efficacy against UV-radiation. BLUVE G., and THCHMLETLER, E. E SOFW Journal, 1999, 125 (1), 12–14.
  • Liver-targeting delivery system for cantharidin polyphase liposomes modified by strength-ened targeting material. Fig mr., YANG J., YANG J., and YIN W. Zhongguo Yaoke Daxue Xuebao, 1998, 29 (6), 413–417.
  • Long-acting microcapsules of pyrimethamine for chemoprophylaxis of malaria. BHALLA, H. L., and MENCIN M. D. Indian Drugs, 1998, 35 (11), 705–710.
  • Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumors in mice using apolipoprotein E-enriched liposomes. VERSLUIS, A. J., RENSEN P. C. N., RUMF, E T., VANBERKEL, T. J. C., and BLISTERECSQ1 M K British Journal of Cancer, 1998, 78 (12), 1607–1614.
  • Low-molecular-weight heparin-conjugated liposomes with improved stability and hemo-compatibility. KCEE, G. T., ARICA, M. Y., and HASIRCL V. Drug Delivery, 1998, 5 (4), 257–264.
  • Lysosome-disrupting peptide increases the efficiency of in-vivo gene transfer by liposome-encapsulated DNA BARU M., NAHUM 0, JAARQ H., SHAANAN, J., and NU, I. Journal of Drug Targeting, 1998, 6 (3), 191–199.
  • Mechanical strength of single microcapsules determined by a novel micromanipulation technique. ZH4NI Z., SAUNDERS, R., and THaMAS, C. R Journal of Microencapsulation, 1999, 16 (1), 117–124.
  • Mechanism of accumulation of double labeled 3H/99m Tc-liposomes in lung and alveolar surfactant. NINCI S., KOATCHEVA S., NEITCHEVA, T., and PETITYA D. Farmatsiya (Sofia), 1997, 44 (3-4), 18–22.
  • Metabolism of the new liposomal anticancer drug N4-octadecy1-1-beta-D-arabinofuranosyl-cytosine in mice. KCLLER, L. S. K, SUTER, M. J., RENTSQ1 K M., SCHOTT, H, and SCHMENCENER, R. A. Drug Metabolism and Disposition, 1999, 27 (3), 342–350.
  • Methods and applications of microencapsulation of food additives. JIANG Z Shipin Gongye Keji, 1998, (5), 73–75.
  • Microcapsules for the textile industry. KUKCMC M., KNE4 E, and PIPAL V. Tekstilec, 1998, 41 (7-8), 225–230.
  • Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release. HUAIN, R. G., SCHWART4 J. B., and OFNER, C. M III. Pharmaceutical Developments and Technology, 1999, 4 (1), 107–115.
  • Microencapsulation of menthol and modified starch. LI, G, and XIAQ L. Shipin Kexue (Beijing), 1998, 19 (7), 40–42.
  • Microencapsulation process factors which influence the sphericity of 1 mm o.d. poly(alpha-methylstyrene) shells for ICF. MCQUILLAN B. W., and GREENACCO A Fusion Technology, 1999, 35 (2), 194–197.
  • Microspheres obtained by multiple emulsions. LAMAS, C, FRIAS, M, MIMI* C., and VHA2QUE4 R. Boll Chim Farm, 1998, 137 (9), 357–361.
  • Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres. URATA T., ARIM:RI, K, and NAKANO H. Journal of Controlled Release, 1999, 58 (2), 133–141.
  • Molecularly imprinted monodisperse microspheres for competitive radioassay. Yg L., CCR1MACK, P. A. G., and MCSPACF1 K. Analytical Communications, 1999, 36 (2), 35–38.
  • Monodisperse microspheres exhibiting discontinuous response to temperature change. MATSUCKA, H., FUNMDTQ K, and KAWAGUCH, H. Polymer Gels Networks, 1999, 6 (5), 319–332.
  • Morphogenesis of liposomes encapsulating actin depends on the type of actin-crosslinking. HCNCA, M., TAKIGUCH, K, ISHKAWA S., and HOTAN, H. Journal of Molecular Biology, 1999, 287 (2), 293–300.
  • Morphological behavior of acidic and neutral liposom es induced by basic am phiphilic alpha-helical peptides with systematically varied hydrophobic-hydrophilic balance. KITANURA, A., KIYOTA, T., TONCHRQ M., UNEDA, A, LIT S., INDLX T., and SHOHAM, G. Biophysical Journal, 1999, 76 (3), 1457–1468.
  • Morphological transformation of liposomes caused by assembly of encapsulated tubulin and determination of shape by microtubule-associated proteins (MAPs). KAMM) T., ITCH T. J., and HOME, H. Journal of Molecular Biology, 1998, 284 (5), 1671–1681.
  • Morphological transformation of liposomes caused by assembly of encapsulated tubulin or actin with associated proteins. HCN)A, M., TAKIGUCH, K, KAINEKQ T., and HOCANI, H. Seibutsu Butsuri, 1999, 39 (1), 14–17.
  • Multilamellar cationic liposomes are efficient vectors for in vitro gene transfer in serum. RCES, P C., HENSEN M. L., SUPABFI-EL R., and HLI, S. W. Journal of Liposome Research, 1998, 8 (4), 499–520.
  • Novel bioresorbable and bioeliminable surfactants for microsphere preparation. Bounkog P, BAPAK, V., and DELLACHERIE, E. Pharmaceutical Research, 1999, 16 (1), 148–154.
  • Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. BANDYCPADHYAY, P., MA, X., LINEHAN S. C., KREN B. T., and STEER, C J. Journal of Biological Chemistry, 1999, 274 (15), 10163–10172.
  • On the validity of blood flow measurement using colored microspheres. HCCEIGE D., DEPAUW, M., EECHAUTE, W, WEYI* J., and HaN:RICIOc G. R. American Journal of Physiology, 1999, 276 (4 Pt 2), H1150–H1158.
  • Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity. CFM, C. M., GHARAVI, A. E, and CHAINEVICH H Biochimica et Biophysica Acta, 1999, 1416 (1-2), 225–238.
  • Optical microsphere resonators: optimal coupling to high-Q whispering-gallery modes. GCRODETSKY, M. L., and ILCHENKQ V. S. Journal of the Optical Society of America B, 1999, 16 (1), 147–154.
  • Optimization of preparative conditions for poly-m-lactide- polyethylene glycol microspheres with entrapped Vibrio cholera antigens. DEIN, X. M, LI, X. H., YUAN M. L., XICNU C. D., HUN Z T., JIA, W. X., and ZHAI\ Y. H. Journal of Controlled Release, 1999, 58(2), 123–131.
  • Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity. MCALISTER, V. C., KESFIAVAMILTFIV, M., and LEE T. D. Transplantation Proceedings, 1999, 31 (1-2), 1110.
  • Oxidative stability of liposom es prepared from soybean PC, chicken egg PC, and salmon egg PC NARA, E, MIYASHITA K, and OTA T. Bioscience, Biotechnology, and Biochemistry, 1997, 61 (10), 1736–1738.
  • Paramagnetic liposomes as 1VIRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. FCESHEIM S. L., FAHLVIK A. K., KLAVEINESS, J., and MULLEt, R. N. Magnetic Resonance Imaging, 1998, 17 (1), 83–89.
  • Particle size and loading efficiency of poly(D, L-lactic-coglycolic acid) multiphase micro-spheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods. IWATA M., NAKAMJRA, Y., and MCGINTY, J. W. Journal of Microencapsulation, 1999, 16 (1), 49–58.
  • Partitioning of triphenylalkylphosphonium homologues in gel bead-immobilized liposomes: chromatographic measurement of their membrane partition coefficients. YAI\U; Q, LII4 X. Y., UNETAINI, K, KAM) N., and MIYAKE J. Biochimica et Biophysica Acta, 1999, 1417 (1), 122–130.
  • Pegylation of liposom es in cell-specific targeting: it does not always make sense. SCHERIATF, GL., KCNIIN G. A., KAM'S, J. A. A. M., and DAEIVEN T. NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 49–59.
  • Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. KIM A., YUN M. O., OH Y. K., AHNI W. S., and KIM C. K International Journal of Pharmacy, 1999, 180 (1), 75-81. Phase I study of liposomal vincristine. Ga.M:=N A., TCLCH132, A., DIAR A. R., BALLY, M. B., EACREE, L., HUIDCN N., DEDHAR, C., AYERS, D., EISEN A., MELCSKY, R, BURGE C, LCCIAN P, and MAYER, L. D. Journal of Clinical Oncology, 1999, 17 (2), 697–705.
  • Physical conjugation of (tri-) block copolymers to liposomes toward the construction of sterically stabilized vesicle systems. KCSTARELC) K, TAERCS, TH F., and LUCKHAM P. F. Langmuir, 1999, 15 (2), 369–376.
  • Physico-chemical properties of borate derivatives of DOPA, dopamine, and their liposome forms. BCRISCWA N. V., KRIUKCY, V. I., KAFLUN A. P, and SHVETS, V. I. Bioorganicheskaia Khimiia, 1998, 24 (11), 8118 855.
  • Physiologically based pharmacokinetic model for fluorocarbon elimination after the admin-istration of an octafluoropropane-albumin microsphere sonographic contrast agent. HUTTER, J. C., LULI H. M., MEHLHAFF, P. M., KILLAM A. L., and DTTTRICH H. C. Journal of Ultrasound in Medicine, 1999, 18 (1), 1–11.
  • Pilot study on manufacturing of theophylline microcapsules by the congelation phase separation method. VC) X. M., and NGUYEN T. L. Tap Chi Duoc Hoc, 1998, (10), 23–24.
  • PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryo-preparation and carbohydrate stabilization. ANDC) S., PUTNAM D., PACic D. W., and LANGER, R. Journal of Pharmaceutical Sciences,1999, 88 (1), 126–130.
  • Polarized TH1 responses by liposome-entrapped allergen and its potential in immunotherapy of allergic disorders. SEHRA, S., CHUG-I L., and GAINGAL, S. V. Clinics in Experimental Allergy, 1998, 28 (12), 1530–1537.
  • Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. PHILLIFS, W. T., KLIFFER, R. W., AWASTH, V. D., RUDCLIH A. S., CLIFF, R., KWASIBCRSKI, V., and GUINS, B. A. Journal of Pharmacology and Experimental Therapy, 1999, 288 (2), 665–670.
  • Polyphosphazene membranes and microspheres in periodontal diseases and implant sur-gery. VERCNESE F. M., MARSILIQ F., LCRA, S., CALICETI, P, PASSI, P, and CRSCLINI, P. Biomaterials, 1998, 20 (1), 91–98.
  • Preparation and characteristics of rumen-bypass microcapsules for improvement of produc-tivity in ruminants. Y031-1(MARLI T., SHIPATA M., FUKLJGCM=RI, T., and MATSUIVDFQ K Journal of Agriculture and Food Chemistry, 1999, 47 (2), 554–557.
  • Preparation and characterization of ofloxacin microspheres for the eradication of bone associated bacterial biofilm. HAMA M., ONYILCKR, S., EBUW N. K, and ONALISLI A. G. Journal of Microencapsulation, 1999, 16 (1), 27–37.
  • Preparation and testing of liposomes and its application in cosmetics. ZHAQ X., LIU, J., CHAI, T., and DIN U Y. Riyong Huaxue Gongye, 1998, (5), 8–11.
  • Preparation of cyclosporin liposom al ointment. ZHAQ H., EIL1 M, ZHIEN J. M, andZHANi Y. H. Zhongguo Y iyao Gongye Zazhi, 1998, 29 (11), 490–493.
  • Preparation of glass microspheres for LCD. CAQ Z, ZHAN X., ZHAQ Z, and LI, L. Proceedings of the S PIE-International Society of Optical Engineering, 1998, 3557 (Current Developments in Optical Elements and Manufacturing), 51–54.
  • Preparation of hydrogel microcapsules. Effects of preparation conditions upon membrane properties. MAKING) K., UIVETSL1 M., KIKUCHI, A., OFBHImA, H., SAKLRAI, Y., and OKANQ T. Colloids Surfactant, B, 1998, 12 (2), 97–104.
  • Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy. KNQ K, H, FLIIICKA, K., FUKUNCRI, Y., AKII* Y., and TCKUUYE K Chemical Pharmaceutical Bulletin, 1999, 47 (1), 54–63.
  • Preparation of m agnetic gelatin microspheres and their properties. QI1.1 G., and (T G Shipin Kexue (Beijing), 1998, 19 (11), 7–11.
  • Preparation of microcapsule of CaCO3 encapsulated in CPVC. WAN L., WAN L., ZEILI L., and LI, S. Gaofenzi Cailiao Kexue Yu Gongcheng, 1999, 15 (1), 161–163.
  • Preparation of microcapsules containing TiO2 used by in-situ polymerization. MISHIMA, K, MATSUYAMA, K, ITQ Y., EZAWA, M., TARUTA Y., and NAGATAN, M Fukuoka Daigaku Kogaku Shuho, 1998, 61, 187–189.
  • Preparation of microspheres of ketoprofen with acrylic polymers by a quasi-emulsion solvent diffusion method. IM M. I., and BISCAINS, B. Powder Technology, 1999, 101 (2), 120–133. Preparation of neoglycoprotein-liposome conjugates and their applications for studying recognition functions based on membrane-surface carbohydrate-protein interactions. YAMAZAKI N. Busshitsu Kogaku Kogyo Gijutsu Kenkyusho Hokoku, 1998, 6 (5), 199–211. Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. VISWANATHAN N. B.,P A., PANDIT, J. K,KULKARNI, M. G., and MASHELKAIL R A. Journal of Controlled Release, 1999, 58 (1), 9–20.
  • Preparation of silica microspheres containing UV-shielding materials by impregnation method and their UV-shielding ability. KURCKL 0, MIZUGUCH, M, NCGUCH, M., and KA1VIATA S. Shikizai Kyokaishi, 1999, 72 (2), 88–94.
  • Production of microsphere and microcapsule using supercritical carbon dioxide. MISHIMA K, and MATSUYAMA K Hyomen, 1998, 36 (11), 607–613.
  • Production of titanate microspheres by sol-gel and spray-dying. SIZGER E, BARTLETT, J. R., and BUMS, M. P Journal of Sol-Gel Science Technology, 1998, 13 (1/2/3), 1011–1016.
  • Properties of cationic liposomes composed of cationic lipid YKS-220 having an ester linkage: adequate stability, high transfection efficiency, and low cytotoxicity. OHM S., YLI W, SHIALNAmA, A., UNEDA, T., MINAM, T., MIYASHTA K, DO, T., and IMANSH, T. Biological Pharmaceutical Bulletin, 1999, 22 (2), 187–190.
  • Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation. RINGDEN 0, ANESTROM E. E., REmBERCIER, M., DAHLLCF, G, SVAHN R M, and TCLLEMAR, J. Pediatric Transplantation, 1997, 1 (2), 124–129.
  • Protective role of target-liposome carried calcitonin gene-related peptide in balloon denuded rat aorta. SHABTCFLI D., WAN X. H., LIU N. K,L. Z, PEN? S. Q,and TANUs C. S. Zhongguo Yaolixue Tongbao, 1998, 14 (4), 336–338.
  • Protein-mediated DNA transfer into liposomes. LAMBERT, 0, PLAN:GUS L., RICAULI J. L., and LETELLIER, L. Molecular Microbiology, 1998, 30 (4), 761–765.
  • Protrusive growth from giant liposomes driven by actin polymerization. MIYATA H., NISHIYAmA, S., AKASHI K., and KINCSTTA K JR Proceedings of the National Academy of Sciences of the United States of America, 1999, 96 (5), 2048–2053.
  • Pulmonary gas-exchange analysis by using simultaneous deposition of aerosolized and injected microspheres. ALTEIVIIER, W. A., RCBERTSCN T. H., and GLENNY, R. W. Journal of Applied Physiology, 1998, 85 (6), 23/11I 2351.
  • Pyrene fluorescence dynamics within a polymer microspherical cavity. FUIWARA H., SASAKI, K, and MASUHARA H. Journal of Applied Physics, 1999, 85 (4), 2052–2056.
  • Quasi orbital motion of ultra cold excited atomic dipole near dielectric microsphere. KLIMCN, V., LETCKEEkr, V. S., and DUCLCK M. European Physics Journal D, 1999, 5 (3), 345–350.
  • Radiopharmaceuticals for lung scintigraphy: spectrophotometry of Sn (II) in albumin micro-spheres modified by stannous chloride. POTAFUTA, Z M, EISHTEIN N. B., KHLESKCJi, V. I., STAROXITOTA, L. P., and KHARLAMN, V. T. Med Racliol Radiats Bezop, 1998, 43 (5), 52–56.
  • Raman spectroscopic study of photodam age on the space structure of DL-a-phosphatidylcho-line liposomes sensitized by hypocrellin B. XI I Y., YANG H., YAN Y., and ZHANG Z Journal of Photochemistry and Photobiology, B, 1998, 45 (2–3), 179–183.
  • Recent developments in the biomedical and functional microspheres. YCN:CHUN C., SHIYUAN C, and GLIJUN Z. Hubei Daxue Xuebao, Ziran Kexueban, 1998, 20 (4), 364–368.
  • Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. WCRKINU P. K, NEWMAN M S., SULLIVAN T., and YARRINGIEN J. Journal of Pharmacology and Experimental Therapeutics, 1999, 289 (2), 1128–1133.
  • Relationship of dose intensity to the induction of palmar-plantar erythrodysesthia by pegy-lated liposom al doxorubicin in dogs. AMANITA, M., NEWMAN M S., SULLIVAN T. M., FCRREST, A., and WCRKING P. K. Human and Experimental Toxicology, 1999, 18 (1), 17–26.
  • Release mechanisms of pH-sensitive liposomes. Gg S. R, and PH, Y. Y Zhongguo Y iyao Gongye Zazhi, 1998, 29 (12), 564–568.
  • Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods. HAVANU S. H., MAITASI, Y., QI, X. R., TAKAYAMA, K, and NAGAI, T. International Journal of Pharmacy, 1999, 179 (1), 85–95.
  • Reversal of methotrexate resistance in human squamous carcinoma cells by SQM1-lipo-some. WCKU Y. C., and BERNAL, S. D. Anticancer Research, 1999, 19 (1A), 251–254.
  • Rheological properties of UV curable microcapsule ink. NAKAMJRA, S., HAYASHI, N., ISHR, C., KCSEKI, K, AMR1 T., HIGURASHL H., HIRASAWA A., and ETU-I K Nippon Insatsu Galdfaishi, 1998, 35 (6), 508–512.
  • Role of liposomes in selective proliferation of splenic lymphocytes. SE-RA S., CHDat L., and GANGAL, S. V. Molecular and Cellular Biochemistry, 1998, 183 (1-2), 133–139.
  • Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tum ors. BOARLI, A., POZ1I, A., SALMACKI, A, ECU, M., ZUCCFEITI, M., and SILVAN, A. Cancer Chemotherapy and Pharmacology, 1999, 43 (2), 178–179.
  • Self-assembly and immobilization of liposomes in fused-silica capillary by avidin-biotin binding. YANU Q., LIU X. Y., MIYAKg J., and TCYOTAMA, H Supramolecular Science, 1998, 5 (5-6), 769–772.
  • Separation of human bladder cancer cells from bone marrow with a kind of im munom ag-netic microspheres.KANU J., BUKA, S., XIg S., and 'NH, S. Yaoxue Xuebao, 1998, 33(1), 52–56.
  • Short term stability of freeze-dried, lyoprotected liposomes. VAN WISIDEN E C, and CRCMVEUN D. J. Journal of Controlled Release, 1999, 58 (1), 69–86.
  • Silicone microspheres for pH-controlled gastrointestinal drug delivery. CAREW, V., CCLTEU1, S., DIM() G., NANNIHERI, E, and SBIASI, M. F. International Journal of Pharmacy, 1999, 179 (1), 73–83.
  • Skin delivery of a hybrid liposome/ISCOM vaccine implicates a role for adjuvants in rapid modulation of inflammatory cells involved in innate immunity before the enhance-ment of adaptive immune responses. CHIN J., and SANG. F. Immunology and Cell Biology, 1998, 76 (3), 245–255. 53 Refs.
  • Some aspects of the hydrodynamics of the microencapsulation route to NIF mandrels. GRESFE) P. M. Fusion Technology, 1999, 35 (2), 157–188.
  • Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E.-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo. VERSLULS, A. J., RUMF, E T., MENNEN P. C., VANBERKEL T. J., and BLISTERECKFt M. K Journal of Pharmacology and Experimental Therapeutics, 1999, 289 (1), 1–7.
  • Steric stabilization of cationic liposome-DNA complexes: influence on morphology and transfection activity. STERNPER, B., HCING K, ZHEING W, and PAPAHADJCPCULCK D. NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 185–191.
  • Structural changes of poly(lactic acid) (PLA) microspheres under hydrolytic degradation. GCNZ41E4 M. F., RLSBCKAITg R. A., and CUAERADC) T. R Journal of Applied Polymer Science, 1999, 71 (8), 1223–1230.
  • Structure—activity relationships for antioxidant activities of a series of flavonoids in a liposom al system. ARCRA, A., NAIR, M. G, and STRASBIRQ G M Free Radical Biology and Medicine, 1998, 24 (9), 1355–1363.
  • Studies on chitosan prepared from silkworm pupae as materials for microcapsule. TAI, N., JI, X., ZFUANU D., and YUAN Z Canye Kexue, 1998, 24(3), 170–174.
  • Studies on drugs absorption using liposome to simulate biomembrane. LUDY. J., SHEN H. X., LIU H. T., and KCING D. M. Gaodeng Xuexiao Huaxue Xuebao, 1998, 19 (11), 1730-1734. Study of polyfunctional carboxyl telechelic microspheres. XIF D. L., HQ Y., SHEN Q D., and YANG C Z Journal of Applied Polymer Science, 1999, 72 (5), 667–676.
  • Study of the inactivation process of the tetanus toxoid in contact with poly(lactic/glycolic acid) degrading microspheres. TCHQ M., and ALCESQ M J. ST P Pharma Sciences, 1998, 8 (5), 303–310.
  • Study on acute toxicity and antitumor effects of liposom al adriamycin. WAN J., SU, D., and GLI X. Zhongguo Yaware Zazhi (Beijing), 1998, 33 (11), 658–660.
  • Study on microencapsulation of fish oil with soybean protein by spray-drying method (I)-selection of microcapsule's wall compositions. ail X., and XI 1 S. Zhongguo Y ouzhi, 1998, 23 (5), 31–34.
  • Study on microencapsulation of sesame oil. TAN Y., XI, G., and CH, J. Zhongguo Y ouzhi, 1998, 23 (5), 35–36.
  • Study on mitoxantrone carboxym ethyl starch microspheres for hepatic artery chemoembo- lization. ZH4NI Z., WH, Z., WAIN L., and LIAQ F. Yaoxue Xuebao, 1998, 33 (10), 772–777. Study on preparation of Spirulina microcapsules. XI J J., ZHAQ M., and PEN? Z Shipin Gongye Keji, 1998, (4), 13–14.
  • Surface synthesis of zinc sulfide nanoparticles on silica microspheres: Sonochemical pre-paration, characterization, and optical properties. DI-IAS, N. A, ZAEAN A, and GEEANKEN A. Chemical Materials, 1999, 11 (3), 806–813.
  • Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. RCSER, M., FISCHER, D., and KISSEL, T. European Journal of Pharmaceutics and Biopharmaceutics, 1998, 46 (3), 255–263. Sustained enhancement of liposom e-m ediated gene delivery and gene expression in human breast tumour cells by ionizing radiation. JAIN P T., and GENNIRT4 D. A International Journal of Radiation Biology, 1999, 75 (2), 217–223.
  • Sustained-release polyurethane microcapsules. KATACKA, H., and HAYASHI, A Porima Daijesuto, 1999, 51 (2), 70–80.
  • Synthesis and structural ordering of core-shell polymer microspheres. ISHIZU K. Progress in Polymer Science, 1998, 23 (8), 1383–1408.
  • Systemic and regional hemodynamics assessment in rats with fluorescent microspheres. GERVAIS, M., DEM:US, P., DOVERGUE V., LESAGE M., RICHER, C., and GILLICELLI, J. F. Journal of Cardiovascular Pharmacology, 1999, 33 (3), 425–432.
  • Tailored modification of quartz surfaces by covalent immobilization of small molecules (gam m a-am inopropyltriethoxysilane), monodisperse macromolecules (dendrimers), and poly(styrene/acrolein /divinylbenzene) microspheres with narr. M1KSA, B., SLCIVKOASKI S., CHEHIM, M. M., DELAmAR, M., MAKRAL, J. P., and CAmNADE A. M. Colloid Polymer Science, 1999, 277 (1), 58–65.
  • Target-cell specificity of fusogenic liposom es: Membrane fusion-mediated macromolecule delivery into human blood mononuclear cells. WATABE A, YAMAGUCHI, T., KAWANISH, T., UCEI.EA, E., EGIKH, A., MIZUGUCH, H., MAYUM, T., NAKANSH, M, and HAYAKAWA, T. Biochimica et Biophysica Acta, 1999, 1416 (1-2), 339–348.
  • Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. GABIZCN A., HCROMT4 A T., GCREN D., TZEM4C.11 D., MANDELEALIVI S. F., QAzEts M. M., and zAursKY, S. Bioconjugate Chemistry, 1999, 10 (2), 289–298.
  • Targeting macrophages with microspheres containing cytokine-neutralizing antibodies pre-vents lethality in gram-negative peritonitis. OETTINUER, C. W., DSCUZA, M, and MILTCIN G. V. Journal of Interferon Cytokine Research, 1999, 19 (1), 33–40.
  • Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium -99m -HMPAO-granulocytes and technetium -99m -HYISTIGIgG. DANE, E T. M., OYES W. J. G, BCERMAN 0. C., STCRIVI G., LAVERMAN P, KCIENDERS, E B., VANDER MEER, J. W. M., and CCRSTENS, F. H. M. Journal of Nuclear Medicine, 1998, 39 (12), 2172–2178.
  • Technology of hollow glass microsphere filled with Ne for laser fusion. MA, H., YL1 B., TANU Y., ZHIFNG Y., LI, X., WEN S., and YUAN Y. Qiangjiguang Yu Lizishu, 1998, 10 (4), 578–580.
  • Temperature dependence of ionic transport through gramicidin a channels in liposomes: an EtS study. VALLUQ A E., GERVASI, C. A., and GASSA, L. M. Bioelectrochemistry and Bioenergy, 1998, 47 (2), 343–348.
  • The characterization and release kinetics evaluation of baclofen microspheres designed for intrathecal injection. CRUAUT1 0, BEINITA S., and BENUT, J. P International Journal of Pharmacy, 1999, 177 (2), 247–257.
  • The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, liposomes with L-DOPA and 'empty' liposomes on the phospholipid composition of the murine liver. PCDCCRNYI, G N., NAMESINKCYA, I. V., and SUI_SAK N. N. Ekverimentalnaia I Klinicheskaia Farm-akologiia, 1999, 62 (1), 41–44.
  • The in vivo delivery of heterologous proteins by microencapsulated recombinant cells. 0-141\ P L., VAN RAAIVEDCNK J. M., HCRTELANQ G, BARSCUM S. C, MACDCNALD N. C., and STCCKLEY, T. L. Trends in Biotechnology, 1999, 17 (2), 78–83. 41 Refs.
  • The mononuclear phagocyte system: features relevant to interactions with liposomes. Go:MOS S. NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 15–23.
  • The relationship of interaction forces in the protein adsorption onto polymeric microspheres. )(OEN J. Y., KIM J. H., and KIM W. S. Colloids Surfactant, B, 1998, 12 (1), 15–22.
  • The role of hydration in stabilization of liposomes: resistance to oxidative damage of PEG-grafted liposomes. PRIEV, A., SAWN, A. M., TIRCSI-1 O., and BARENtia4 Y. NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 147–167.
  • The transport of polymeric microspheres across the ciliated epithelia of the bullfrog. APDEL HAIVEED M. D., BAKER, H. J., and KELLAWAY, I. W. International Journal of Pharmacy, 1999, 180 (1), 59–67.
  • The use of CaCl2 and other salts to improve surface finish and eliminate vacuoles in ICE microencapsulated shells. MCQUILLAN B. W., ELSNER, F. H., STETHENS, R B., and BROAN L. C. Fusion Technology, 1999, 35 (2), 198–201.
  • The use of liposomes as snake venom vehicles: application in protective immunization. FREITAS, T. V., DINg C. R., and FREZARQ F. Journal of Toxicology, Toxin Review, 1998, 17(4), 441–461.
  • Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encap-sulated in long-circulating pegylated stealth liposomes. VAAGE J., DCNNAN D., WITFF, E., AMA, R., CCLPERN G., USTHL, P., and WCRICEN P International Journal of Cancer, 1999, 80 (1), 134–137.
  • Thermosensitive polymer-modified liposomes that release contents around physiological temperature. KCNCI K, NAKAI, R., MCRIIvIOTO K., and TAKAGESH, T. Biochimica et Biophysica Acta, 1999, 1416 (1-2), 239–250.
  • Topical anesthesia of intact skin: liposome-encapsulated tetracaine vs EMLA. FISHER, R., HLINU 0, MWFI, M., and STEWART, R. British Journal of Anaesthesiology, 1998, 81 (6), 972-973. Topical liposome delivery of molecules to hair follicles in mice. LI, L., and HCEEMAINS R. M. Journal of Dermatological Science, 1997, 14 (2), 101–108.
  • Toxicity of gamma irradiated liposomes. 1. In vitro interactions with blood components. STENSRLD, G., PASSI, S., LARSEN T., SAN:SET, P. M, SMSTAD G., MCNKKthEN J., and KARLSEN J. International Journal of Pharmacy, 1999, 178 (1), 33–46.
  • Toxicity of gamma irradiated liposomes. 2. In vitro effects on cells in culture. STENSRUCt G., MCNKKCNEN J., and KARLSEN J. International Journal of Pharmacy, 1999, 178 (1), 47-53. Trace study of slow release on gelatin microsphere. TC1NG J., LI, Y., FEN Y., LI, H, and NILI H. Tongweisu, 1998, 11 (3), 168–171.
  • Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposom al lipid and liposom al protein. RAQ M., ROTEMELL S. W, WASSEF, N. M., KCCLWAL, A. B., and ALVIN C. R. Experimental Cell Research, 1999, 246 (1), 203–211.
  • Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. KULSEIN. R, SKJAK, B. G., RYAN L., ANDERSSON A., KIN A., FAX'VAAQ A., and ESFEVIK T. Transplantation, 1999, 67 (7), 978–984.
  • Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposom al am photericin-B. KRUGER, W. H., KRCGER, N, RthSMANS B., MEN, H, KAMM H., and ZANDER, A. R. Bone Marrow Transplantation, 1998, 22 (Suppl 4), S10—S13.
  • Treatment with liposome-bound recombinant human tumor necrosis factor-alpha sup-presses parasitemia and protects against Plasmodium berghei k173-induced experi-mental cerebral malaria in mice. PCSTMA, N. S., CRCWELES D. J. A., ELIN W. M. C., and ZUDEMA, J. Journal of Pharmacology and Experimental Therapy, 1999, 288 (1), 114–120.
  • Ultralow threshold laser using a single quantum dot and a microsphere cavity. PELTCN M., and YAMAMOTO Y. Physics Review A: Atomic, Molecular, and Optical Physics, 1999, 59 (3), 2418–2421.
  • Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. MEYINELL, H M, TITIMA,S, N. W, JAMES, P S., HCII_AINT) J., TALESIQ M. J., and NIOaETTI, C. Faseb Journal, 1999, 13 (6), 611–619.
  • Uptake of liposomes containing phosphatidylserine by liver cells in vivo and by sinusoidal liver cells in primary culture: in vivo—in vitro differences. KAMS, J. A., MCRSELT, H. W, and SCHERFILF, G. L. Biochemical and Biophysical Research Communications, 1999, 256 (1), 57–62.
  • Urethane-based slow releasing type microcapsules. KATACKA, H., and HAYASHI A. Shaho - Daiichi Kogyo Seiyaku Kabushiki Kaisha, 1999, 511, 15–21.
  • Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty. CCINSIGNY, P M., SILVERBERG D. A., and VITALI, N. J. Journal of Vascular and Interventional Radiology, 1999, 10 (2 Pt 1), 155–163.
  • Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. YAN T. H., D(NI A, MEYER, J., JCHINSCIS 0 L., CLELAND, J. L., and CARFENTER J. F. Journal of Pharmaceutical Sciences, 1999, 88 (2), 161–165.
  • Use of radiolabeled liposom es for PEG-liposome-based drug targeting and diagnostic imag-ing applications. PHILL1FS, W. T. NATO ASI Series, Series A, 1998, 300 (Targeting of Drugs 6), 109–120.
  • Using freezing and drying techniques of emulsions for the microencapsulation of fish oil to improve oxidation stability. HEnviIINANs K, and FRAW K Colloids Surfactant, B, 1999, 12 (3-6), 223–229.
  • Visceral leishmaniasis treated with liposomal amphotericin B ATAINIA S., AIASSA, C., TZAFIFZEGLCLI S., CATAINIA N., TUOJARCI* L., ANTIM, A, RAGNI, G, and CLERICO A. Pediatric Infectious Disease Journal, 1999, 18 (1), 73–74.
  • Whispering-gallery mode lasers with doped silica microspheres. LEFEVRE S. V. Optical Materials (Amsterdam), 1999, 11 (2/3), 153–165.
  • Xenotransplantation of cells using biodegradable microcapsules. LANZA R. P, JACKSOS R., SI TI1VAN A, R1NGELIN J., MCGRATH C., KUHTREWER, W., and CHICK W. L. Transplantation, 1999, 67 (8), 1105–1111.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.